Dengue Testing Market Report 2023-2028 PDF, Industry Trend, Analysis and Revenue

1. Dengue Testing Market Report 2023 By Test Type and End User Key Regions and Competitive Landscape www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145 Author: Elena Anderson, Marketing Manager | IMARC Group Copyright © IMARC Service Pvt Ltd. All Rights Reserved © 2019 IMARC All Rights Reserved

2. About IMARC Group Report Description The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Dengue Testing Market Outlook 2023-2028: The global dengue testing market size reached US$ 555.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 761.6 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028. Dengue or breakbone fever is a viral infection transmitted by the bite of an Aedes aegypti mosquito. It causes numerous symptoms such as headaches, high fever, abdominal pain, muscle, bone, and joint aches, vomiting, swollen glands, difficulty breathing, mild bleeding in the nose and gums, and rashes. It is diagnosed using various dengue testing methods, including reverse transcription-polymerase chain reaction (RT-PCR), Dengue IgG/IgM rapid tests, and enzyme-linked immunosorbent assay (ELISA). These tests are conducted by medical professionals using a blood sample to identify the different serotypes of the dengue virus. As a result, dengue testing is widely adopted in research institutes, hospitals, and diagnostic centers.

4. Report Description and Highlights Report Description Global Dengue Testing Market Trends: The market is primarily driven by the increasing incidences of dengue cases on account of poor sanitation and changing climatic conditions, resulting in the growing breeding sites for mosquitos across the globe. In addition, the increasing use of accurate diagnosis as it assists in outbreak control, vaccine development, early detection of severe cases, pathogenesis, case confirmation, clinical trials, academic research, and differential diagnosis of other infectious diseases are contributing to the market growth. Moreover, governments of various countries are spreading awareness among individuals by educating them about the distress of dengue and preventing dengue by self-protection and thermal fogging of insecticides, which represents another growth-inducing factor. Furthermore, mergers and acquisitions and extensive investment in research and development (R&D) activities conducted by leading market players to create highly efficient, cost-effective dengue test kits are also creating a favorable market outlook. Request for a free sample report: https://www.imarcgroup.com/dengue-testing-market/requestsample

5. Report Description and Highlights Report Description • Market Summary: • Breakup by Test Type: • ELISA-based Tests • RT-PCR based Tests • Dengue IgG/IgM Rapid Test • Others • Breakup by End User: • Hospitals • Diagnostic Centers • Others

6. Report Description and Highlights Report Description • Breakup by Region: • North America • Europe • Asia Pacific • Middle East and Africa • Latin America • On account of the aforementioned factors, the market is anticipated to witness strong growth during 2023-2028.

7. Report Description and Highlights Report Description • Competitive Landscape With Key Player: • Abbott Laboratories • Abnova Corporation • CerTestBiotec S.L. • DiaSorin S.p.A. • F. Hoffmann-La Roche AG • InBios International Inc. • NovaTecImmundiagnostica GmbH • OriGene Technologies Inc. • PerkinElmer Inc. • Quest Diagnostics Incorporated • Thermo Fisher Scientific Inc. • View Report TOC, Figures and Tables: https://www.imarcgroup.com/dengue-testing-market

8. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

9. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

10. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com